Clinical Research Directory
Browse clinical research sites, groups, and studies.
A Study of Olanzapine in Participants With Bipolar Disorder.
Sponsor: Boryung Pharmaceutical Co., Ltd
Summary
This study aimed to identify treatment patterns in patients with bipolar disorder receiving olanzapine according to demographic and clinical characteristics and to evaluate the effectiveness of education on weight gain, a side effect of olanzapine, in preventing weight gain.
Official title: A Multicenter, Prospective Observational Study to Evaluate Treatment Patterns and Safety in Patients With Bipolar Disorder Taking Olanzapine
Key Details
Gender
All
Age Range
19 Years - Any
Study Type
OBSERVATIONAL
Enrollment
3000
Start Date
2025-10-30
Completion Date
2027-09
Last Updated
2025-12-04
Healthy Volunteers
No
Conditions
Interventions
Olanzapine
As this is a non-interventional study designed to collect data as part of routine clinical practice, the selection and dosage of medication, treatment period, and whether or not to change it are all based on the clinician's judgment.
Locations (1)
CHA Bundang Medical Center
Seongnam, South Korea